Yoshimasa Urasaki

Antiproliferative activity of ecteinascidin 743 is dependent upon transcription-coupled nucleotide-excision repair

Yuji Takebayashi, Philippe Pourquier, Drazen B. Zimonjic et al. · Nature Medicine · 2001 · 345 citations

Protein Function, Antiproliferative Activity, Natural Sciences +6

Topoisomerase I inhibitors: selectivity and cellular resistance

Yves Pommier, Philippe Pourquier, Yoshimasa Urasaki et al. · Drug Resistance Updates · 1999 · 177 citations

Medicine, Pharmacotherapy, Anti-cancer Agent +5

Induction of topoisomerase I cleavage complexes by 1-β- <scp>d</scp> -arabinofuranosylcytosine (ara-C) <i>in vitro</i> and in ara-C-treated cells

Philippe Pourquier, Yuji Takebayashi, Yoshimasa Urasaki et al. · Proceedings of the National Academy of Sciences · 2000 · 109 citations · Full text

INNO-406, a novel BCR-ABL/Lyn dual tyrosine kinase inhibitor, suppresses the growth of Ph+ leukemia cells in the central nervous system, and cyclosporine A augments its in vivo activity

Asumi Yokota, Shinya Kimura, Satohiro Masuda et al. · Blood · 2006 · 102 citations · Full text

Characterization of a novel topoisomerase I mutation from a camptothecin-resistant human prostate cancer cell line.

Yoshimasa Urasaki, Gary S. Laco, Philippe Pourquier et al. · PubMed · 2001 · 98 citations

Cpt Derivatives, Crystal Structure, Oncogenic Agent +14